Charles River Laboratories International (CRL) Non-Current Assets (2009 - 2025)
Charles River Laboratories International (CRL) posted quarterly Non-Current Assets of $5.7 billion for Q4 2025, down 7.13% year-over-year from $6.1 billion in Q4 2024, and down 4.9% quarter-over-quarter from $6.0 billion in Q3 2025.
Charles River Laboratories International (CRL) Non-Current Assets (2009 - 2025) Analysis & Trends
Charles River Laboratories International's Non-Current Assets history runs 17 years deep, the most recent figure standing at $5.7 billion for Q4 2025.
- In Q4 2025, Non-Current Assets fell 7.13% year-over-year to $5.7 billion; the TTM figure through Dec 2025 stood at $23.8 billion (down 6.77% YoY), while the FY2025 annual figure was $5.7 billion, down 7.13% from the prior year.
- Non-Current Assets for Q4 2025 stood at $5.7 billion, down from $6.0 billion in the prior quarter.
- The five-year high for Non-Current Assets was $6.6 billion in Q4 2023, with the low at $4.4 billion in Q1 2021.
- The 5-year median for Non-Current Assets is $6.1 billion (2024), against an average of $6.0 billion.
- The sharpest annual moves came in 2021 and 2025: Non-Current Assets surged 36.1% in 2021, then retreated 8.1% in 2025.
- Charles River Laboratories International's Non-Current Assets stood at $5.8 billion in 2021, then climbed by 7.19% to $6.2 billion in 2022, then advanced by 6.86% to $6.6 billion in 2023, then dropped by 7.0% to $6.1 billion in 2024, then retreated by 7.13% to $5.7 billion in 2025.
- Business Quant data shows CRL's Non-Current Assets at $5.7 billion in Q4 2025, $6.0 billion in Q3 2025, and $6.1 billion in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.40 Bn | 209.33 Bn | 8.34 Bn | 89.81 Bn |
| 2 | Danaher | 139.94 Bn | 135.59 Bn | 3.61 Bn | 78.99 Bn |
| 3 | Idexx Laboratories | 46.03 Bn | 45.83 Bn | 779.09 Mn | 1.93 Bn |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn | 8.30 Bn |
| 5 | Iqvia Holdings | 39.32 Bn | 37.24 Bn | 1.44 Bn | 23.66 Bn |
| 6 | Natera | 38.47 Bn | 37.37 Bn | 696.04 Mn | 962.59 Mn |
| 7 | Illumina | 29.98 Bn | 28.82 Bn | 770.00 Mn | 3.82 Bn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.52 Bn | 650.22 Mn | 2.32 Bn |
| 9 | Quest Diagnostics | 26.21 Bn | 25.58 Bn | 1.03 Bn | 14.10 Bn |
| 10 | Charles River Laboratories International | 12.89 Bn | 12.68 Bn | 1.81 Bn | 5.69 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | 5.69 Bn |
| Sep 27, 2025 | 5.98 Bn |
| Jun 28, 2025 | 6.09 Bn |
| Mar 29, 2025 | 6.08 Bn |
| Dec 28, 2024 | 6.13 Bn |
| Sep 28, 2024 | 6.51 Bn |
| Jun 29, 2024 | 6.45 Bn |
| Mar 30, 2024 | 6.48 Bn |
| Dec 30, 2023 | 6.59 Bn |
| Sep 30, 2023 | 6.16 Bn |
| Jul 1, 2023 | 6.27 Bn |
| Apr 1, 2023 | 6.25 Bn |
| Dec 31, 2022 | 6.16 Bn |
| Sep 24, 2022 | 5.97 Bn |
| Jun 25, 2022 | 6.14 Bn |
| Mar 26, 2022 | 5.74 Bn |
| Dec 25, 2021 | 5.75 Bn |
| Sep 25, 2021 | 5.68 Bn |
| Jun 26, 2021 | 5.45 Bn |
| Mar 27, 2021 | 4.39 Bn |